Childhood pneumonia in developing countries

R Izadnegahdar, AL Cohen, KP Klugman… - The Lancet Respiratory …, 2013 - thelancet.com
Pneumonia is a widespread and common infectious lung disease that causes inflammation,
which can lead to reduced oxygenation, shortness of breath, and death. An estimated nearly …

Choice and design of adjuvants for parenteral and mucosal vaccines

HFJ Savelkoul, VA Ferro, MM Strioga, VEJC Schijns - Vaccines, 2015 - mdpi.com
The existence of pathogens that escape recognition by specific vaccines, the need to
improve existing vaccines and the increased availability of therapeutic (non-infectious …

Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens

X Wang, MJ Theodore, R Mair… - Journal of clinical …, 2012 - Am Soc Microbiol
Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae are
important causes of meningitis and other infections, and rapid, sensitive, and specific …

Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines

NL Price, G Goyette-Desjardins, H Nothaft… - Scientific reports, 2016 - nature.com
Abstract The World Health Organization has indicated that we are entering into a post-
antibiotic era in which infections that were routinely and successfully treated with antibiotics …

A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children

RA Karron, C Luongo, B Thumar, KM Loehr… - Science translational …, 2015 - science.org
Respiratory syncytial virus (RSV) is the leading viral cause of severe pediatric respiratory
illness, and a safe and effective vaccine for use in infancy and early childhood is needed …

The future of immunisation policy, implementation, and financing

OS Levine, DE Bloom, T Cherian, C De Quadros… - The Lancet, 2011 - thelancet.com
Vaccines have already saved many lives and they have the potential to save many more as
increasingly elaborate technologies deliver new and effective vaccines against both …

[HTML][HTML] National decision-making for the introduction of new vaccines: A systematic review, 2010–2020

M Donadel, MS Panero, L Ametewee, AM Shefer - Vaccine, 2021 - Elsevier
Background Competing priorities make using a transparent and evidence-based approach
important when deciding to recommend new vaccines. We conducted a literature review to …

Exploring the potential health impact and cost-effectiveness of AIDS vaccine within a comprehensive HIV/AIDS response in low-and middle-income countries

TM Harmon, KA Fisher, MG McGlynn, J Stover… - PloS one, 2016 - journals.plos.org
Background The Investment Framework Enhanced (IFE) proposed in 2013 by the Joint
United Nations Programme on HIV/AIDS (UNAIDS) explored how maximizing existing …

National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis

H Zhang, C Garcia, W Yu, MD Knoll, X Lai, T Xu, R Jing… - BMC medicine, 2021 - Springer
Abstract Background Globally, Haemophilus influenzae type b (Hib) vaccine has
substantially reduced the burden of Hib invasive disease. However, China remains the only …

[HTML][HTML] Progress in introduction of pneumococcal conjugate vaccine—worldwide, 2000–2012

SA Wang, CF Mantel, M Gacic-Dobo… - … and Mortality Weekly …, 2013 - ncbi.nlm.nih.gov
* Eligibility for phase II GAVI Alliance support (2007–2010) was based on having a gross
national income (GNI), in US dollars, of≤ $1,000 in 2003 and diphtheria-tetanus-pertussis …